Navigation Links
LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro

ndidates are proprietary and designed to improve the quality of existing drugs by enhancing the release and absorption of drugs in the human body. LifeCycle Pharma's proprietary technology platform, MeltDose(R) technology, offers lower dosing, reduced side effects and improved safety and patient compliance, as well as reduced product development time and development costs. LifeCycle Pharma is listed on the OMX Nordic Exchange under the trading symbol (LCP). Please visit www.lcpharma.com for further information about LifeCycle Pharma A/S.

CONTACT: For further information please contact: LifeCycle Pharma A/S,Michael Wolff Jensen, Executive Vice President and CFO, Tel.+45-40-74-62-44

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:9/30/2014)... Group finds that the Asia Pacific dental ... , India , Japan ... implant procedure volumes will grow as physicians are increasingly trained on ... findings from Decision Resources Group,s coverage of the Asia ... implant penetration: Penetration of dental implants among the Asia ...
(Date:9/30/2014)... 30, 2014 According ... Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), ... Reagents], Application (Immunology, Oncology) & by End ... by MarketsandMarkets, provides a detailed overview of ... market trends, and strategies impacting the global ...
(Date:9/30/2014)... ANGELES , Sept. 30, 2014   Easy ... shopping destination , today announced that it now offers ... . AirSense CPAPs are the first sleep apnea therapy ... it simple and easy to track and share real-time ... overall effectiveness of their CPAP therapy.  In addition, the ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4
... Immediately Following Transurethral Resection,is Well Tolerated in Phase ... 2007 /PRNewswire-FirstCall/ --,Spectrum Pharmaceuticals, Inc., today announced results ... bladder cancer and the,presentation of preclinical data of ... the American Association of Cancer,Research, held at the ...
... at Society for Biomolecular Sciences Conference, THE ... Genetics Incorporated announced that data was presented,today ... with Genentech, Inc. at the Society for ... Montreal,Canada. These target discoveries were made in ...
Cached Medicine Technology:Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 2Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 3Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 4Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 5
(Date:10/1/2014)... of a rat and a robot could revolutionise advances ... robotics researcher. , Dr Michael Milford from QUT,s ... new computer algorithms to enable robots to navigate intelligently, ... a very Frankenstein type of project," Dr Milford said. ... because we,re taking the eyes of a human and ...
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new ... senior citizens. , Senior citizens can qualify for ... coverage to seniors who are over 50 years old. ... taking a medical examination. , Term life insurance with ... clients can qualify. Having life insurance during retirement is ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 First Warning ... abnormal circadian cellular changes throughout the body, announced the ... to better address the company’s breadth of upcoming product ... breast cancer screening technology. , “Our initial focus will ... system which detects abnormal circadian cellular changes over time,” ...
(Date:10/1/2014)... N.C. A new genetic finding from Duke Medicine ... anxiety and depression might also be hard-wired to gain ... and heart disease. , An estimated 13 percent of ... genetic susceptibility, and knowing this could help them reduce ... diet, exercise and stress management. , "Genetic susceptibility, psychosocial ...
(Date:10/1/2014)... 01, 2014 NoteSwift Inc., announced today ... 10.0, 12.1 and 13.0. NoteSwift is the bridge between ... to navigate and document clinical information at the point ... creating a patient note by more than half – ... major pain points providers state impedes EHR use according ...
Breaking Medicine News(10 mins):Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3
... California, San Francisco has discovered a new way to predict ... relative levels of three types of immune cells within a ... treatment. Moreover, the UCSF team showed that they could ... these drugs to mice, in combination with chemotherapy, significantly slowed ...
... Using new genetic information, scientists have linked a commonly ... reduced risk of bladder cancer, according to findings presented ... 2-6, and simultaneously published in Cancer Prevention Research, a ... Jian Gu, Ph.D., assistant professor of epidemiology at ...
... FRIDAY, April 1 (HealthDay News) -- At-home pregnancy tests can ... the way and if it is time to call your ... tantalizing clues about future health risks -- are still in ... may puzzle or even panic consumers who don,t seek professional ...
... News) -- Reducing cancer patients, stress may benefit their ... chronic stress associated with cancer diagnosis accelerated shortening of ... the chromosome from deteriorating, breaking apart or joining with ... investigators also wanted to see if counseling sessions designed ...
... HealthDay Reporter , FRIDAY, April 1 (HealthDay News) ... wrinkles by freezing the nerves shows promise in early ... approved by the U.S. Food and Drug Administration, could ... injectable forms of Botulinum toxin type A, a neurotoxin ...
... new data presented today at the International Liver CongressTM ... (HCV) patients suppressed the emergence of resistant variants and ... - undetectable HCV RNA - 12 weeks after treatment ... were given four drugs in combination; pegylated Interferon-alpha (PegIFN-alpha); ...
Cached Medicine News:Health News:UCSF team discovers new way to predict breast cancer survival and enhance effectiveness of treatment 2Health News:UCSF team discovers new way to predict breast cancer survival and enhance effectiveness of treatment 3Health News:Genetic variation linked to longer telomeres and lower risk of bladder cancer 2Health News:Do At-Home Genetic Tests Tell Too Much and Explain Too Little? 2Health News:Do At-Home Genetic Tests Tell Too Much and Explain Too Little? 3Health News:Does Stress Reduction Benefit Cancer Patients' Health? 2Health News:Freezing Wrinkles a Possible Alternative to Botox 2Health News:Freezing Wrinkles a Possible Alternative to Botox 3Health News:Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment 2
Jewelers bipolar forceps, 10 cm....
European bipolar foot activated forceps....
Straight, blunt and pointed tips....
Cushing bayonet....
Medicine Products: